Added to YB: 2021-11-03
Pitch date: 2021-11-03
SAVA:US [bearish]
Cassava Sciences, Inc.
+95.75%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases.
Market Cap
$62.8M
Pitch Price
$69.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.47
P/E
-0.89
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Cassava Sciences, Inc. SAVA:US
A summary for this pitch has not been created yet.
Read full article (0 min)